ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide, and the 5-year survival rates are among the worst of the major cancers. Oncolytic herpes simplex viruses (oHSV) have the potential to make a significant impact in the targeted treatment of these patients. Here...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ji Young Yoo, Jun-Ge Yu, Azeem Kaka, Quintin Pan, Pawan Kumar, Bhavna Kumar, Jianying Zhang, Andrew Mazar, Theodoros N Teknos, Balveen Kaur, Matthew O Old
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2015-01-01
coleção:	Molecular Therapy: Oncolytics
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2372770516300109
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!